Peer Review reports
From: Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors
| Original Submission | ||
|---|---|---|
| 20 Aug 2022 | Submitted | Original manuscript |
| 4 Oct 2022 | Reviewed | Reviewer Report |
| 18 Oct 2022 | Reviewed | Reviewer Report |
| 21 Oct 2022 | Author responded | Author comments - Michal Brylinski |
| Resubmission - Version 2 | ||
| 21 Oct 2022 | Submitted | Manuscript version 2 |
| 31 Oct 2022 | Author responded | Author comments - Michal Brylinski |
| Resubmission - Version 3 | ||
| 31 Oct 2022 | Submitted | Manuscript version 3 |
| Publishing | ||
| 7 Nov 2022 | Editorially accepted | |
| 24 Nov 2022 | Article published | 10.1186/s12885-022-10293-0 |
You can find further information about peer review here.